Upgrade to SI Premium - Free Trial

Pre-Open Stock Movers 07/22: (ISRG) (THOR) (EYES) Higher; (XOMA) (ILMN) (AAPL) Lower (more...)

July 22, 2015 9:30 AM
XOMA (NASDAQ: XOMA) 79% LOWER; Phase 3 EYEGUARD-B study of gevokizumab in patients with Bechet's disease uveitis, run by its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles